As of Feb 21
| -1.21 / -6.41%|
The 8 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.25, with a high estimate of 94.00 and a low estimate of 50.00. The median estimate represents a +223.81% increase from the last price of 17.68.
The current consensus among 9 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.